Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Vandooren
Bernard
B
Ghent University Hospital, Ghent, Belgium.
Kruithof
Elli
E
Yu
David T Y
DT
Rihl
Markus
M
Gu
Jieruo
J
De Rycke
Leen
L
Van Den Bosch
Filip
F
Veys
Eric M
EM
De Keyser
Filip
F
Baeten
Dominique
D
D000328:Adult; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D018501:Antirheumatic Agents / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000276:immunology; D015331:Cohort Studies; D015536:Down-Regulation / Q000276:immunology; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D020782:Matrix Metalloproteinases / Q000032:analysis / Q000096:biosynthesis / Q000187:drug effects / Q000276:immunology*; D008875:Middle Aged; D025242:Spondylarthropathies / Q000276:immunology*; D013167:Spondylitis, Ankylosing / Q000276:immunology; D013582:Synovial Fluid / Q000737:chemistry / Q000276:immunology; D013583:Synovial Membrane / Q000276:immunology / Q000473:pathology; D013585:Synovitis / Q000276:immunology*; D019714:Tissue Inhibitor of Metalloproteinases / Q000032:analysis / Q000096:biosynthesis / Q000187:drug effects / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects / Q000276:immunology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D019714:Tissue Inhibitor of Metalloproteinases; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D020782:Matrix Metalloproteinases